These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9594890)

  • 1. Successful thrombolysis of an occluded modified Blalock shunt three days after operation.
    Malm TK; Holmqvist C; Olsson CG; Johansson J; Olsson AK; Sandström S; Bennhagen R; Jögi P
    Ann Thorac Surg; 1998 May; 65(5):1453-5. PubMed ID: 9594890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Blalock-Taussig shunt: technical aspects and postoperative management.
    Swain SK; Dharmapuram AK; Reddy P; Ramdoss N; Raghavan SS; Kona SM
    Asian Cardiovasc Thorac Ann; 2008 Jan; 16(1):7-10. PubMed ID: 18245697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis of a modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect.
    Ries M; Singer H; Hofbeck M
    Br Heart J; 1994 Aug; 72(2):201-2. PubMed ID: 7917699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified central aortopulmonary shunt with end-to-end anastomosis of the shunt to the pulmonary trunk: Early results of a novel shunt procedure for first-stage palliation of infants with pulmonary atresia and hypoplastic pulmonary arteries.
    Ugurlucan M; Sayin OA; Nisli K; Aydogan U; Dayioglu E; Tireli E
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):85-90. PubMed ID: 19241309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balloon dilatation of critically obstructed modified (polytetrafluoroethylene) Blalock-Taussig shunts.
    Marasini M; Dalmonte P; Pongiglione G; Dolcini G; Bosoni M; Ribaldone D; Caponnetto S
    Am J Cardiol; 1994 Feb; 73(5):405-7. PubMed ID: 8109559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic treatment with tissue plasminogen activator in a thrombosed modified Blalock-Taussig shunt].
    Santos de Soto J; Menéndez Gonzlez N; Soult Rubio JA; Grueso Montero J; López Castilla JD; Descalzo Señorans A
    Rev Esp Cardiol; 2001 Sep; 54(9):1113-5. PubMed ID: 11762293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recanalisation of an occluded modified Blalock-Taussig shunt by balloon dilatation.
    Sreeram N; Walsh K; Peart I
    Br Heart J; 1993 Nov; 70(5):474-5. PubMed ID: 8260283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color Doppler imaging of modified Blalock-Taussig shunts during infancy.
    Hofbeck M; Singer H; Wild F; vd Emde J
    Pediatr Cardiol; 1994; 15(4):163-6. PubMed ID: 7527527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Doppler imaging of modified Blalock-Taussig shunts during infancy.
    Hofbeck M; Singer H; Wild F; vd Emde J
    Pediatr Cardiol; 1994; 15(6):163-6. PubMed ID: 7530844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Blalock-Taussig shunt patency for pulmonary atresia: assessment with electron beam CT.
    Okada M; Matsunaga N; Ito K; Takano K; Fujiwara M; Ueda K
    J Comput Assist Tomogr; 2002; 26(3):368-72. PubMed ID: 12016365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occlusion of the modified Blalock-Taussig shunt: unique methods of treatment and review of catheter-based intervention.
    Kogon B; Villari C; Shah N; Kirshbom P; Kanter K; Kim D; Raviele A; Vincent R
    Congenit Heart Dis; 2007; 2(3):185-90. PubMed ID: 18377463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalization of occluded modified Blalock-Taussig shunt using topical recombinant tissue plasminogen activator with balloon angioplasty.
    Suda K; Matsumura M; Matsumoto M
    Cardiol Young; 2004 Jun; 14(3):322-3. PubMed ID: 15680027
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerated thrombolysis facilitated by direct puncture of occluded prosthetic femoral grafts.
    Page JE; Buckenham TM; Taylor RS
    Australas Radiol; 1992 Aug; 36(3):230-3. PubMed ID: 1445106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter treatment for systemic-to-pulmonary artery shunt obstruction in infants and children.
    Gillespie MJ; Rome JJ
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):928-35. PubMed ID: 18383162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tissue plasminogen activator and urokinase in a canine model of prosthetic graft thrombosis.
    Curl GR; Jakubowski JA; Nabseth DC; Bush HL
    Arch Surg; 1986 Jul; 121(7):782-8. PubMed ID: 3087327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter recanalization of acutely occluded modified systemic to pulmonary artery shunts in infancy.
    Sreeram N; Emmel M; Ben-Mime L; Brockmeier K; Bennink G
    Clin Res Cardiol; 2008 Mar; 97(3):181-6. PubMed ID: 18046525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin as a risk factor for perigraft seroma complicating the modified Blalock-Taussig shunt.
    Berger RM; Bol-Raap G; Hop WJ; Bogers AJ; Hess J
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):286-92; discussion 292-3. PubMed ID: 9699582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central aorta-pulmonary artery shunts in neonates with complex cyanotic congenital heart disease.
    Barragry TP; Ring WS; Blatchford JW; Foker JE
    J Thorac Cardiovasc Surg; 1987 May; 93(5):767-74. PubMed ID: 3573789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
    Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
    Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A central shunt to rehabilitate diminutive pulmonary arteries in patients with pulmonary atresia with ventricular septal defect.
    Kim H; Sung SC; Choi KH; Lee HD; Ban GH; Chang YH
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):515-20. PubMed ID: 25454919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.